---
schema_version: "secwatch.filing_event.v1"
accession: "0000950142-21-002677"
form_type: "8-K"
ticker: "NRXP"
cik: "0001719406"
company_name: "NRX Pharmaceuticals, Inc."
filed_at: "2021-08-19T23:59:59+00:00"
generated_at: "2026-06-29T08:57:49.436991+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# NRx Pharmaceuticals CFO William Fricker to leave Aug 30; James Brandon named Acting CFO

## Summary
- William Fricker to depart as CFO and Treasurer effective August 30, 2021; no disagreements cited.
- James Brandon to serve as Comptroller and Acting CFO; Alessandra Daigneault as Acting Treasurer.
- Ira Strassberg hired as financial consultant to lead CFO recruitment; previously Deputy CFO of Cantor Fitzgerald.
- Fricker will receive a $100,000 annual bonus for completing his employment contract.

## SEC filing metadata
- accession: 0000950142-21-002677
- form_type: 8-K
- ticker: NRXP
- cik: 0001719406
- company_name: NRX Pharmaceuticals, Inc.
- filed_at: 2021-08-19T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1719406/000095014221002677/0000950142-21-002677-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1719406/000095014221002677/eh210178862_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950142-21-002677
- JSON: https://secwatch.observer/filing/0000950142-21-002677.json
- Plain text: https://secwatch.observer/filing/0000950142-21-002677.txt

## Key facts
- Executive change
  James Brandon was appointed as Comptroller and Acting Chief Financial Officer at NRX Pharmaceuticals, Inc..
  - Action: appointed
  - Role: Comptroller and Acting Chief Financial Officer
  source text: James Brandon, who served as Comptroller and Acting CFO for NeuroRx, Inc. since inception through 2020, will resume those duties
  evidence_url: https://www.sec.gov/Archives/edgar/data/1719406/000095014221002677/0000950142-21-002677-index.htm
- Executive change
  Alessandra Daigneault was appointed as Acting Treasurer at NRX Pharmaceuticals, Inc..
  - Action: appointed
  - Role: Acting Treasurer
  source text: Alessandra Daigneault, the Company’s General Counsel and Corporate Secretary will serve as Acting Treasurer.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1719406/000095014221002677/0000950142-21-002677-index.htm
- Executive change
  William Fricker departed as Chief Financial Officer (CFO) and Treasurer at NRX Pharmaceuticals, Inc..
  - Action: departed
  - Role: Chief Financial Officer (CFO) and Treasurer
  source text: announced the upcoming departure of William Fricker, Chief Financial Officer (CFO) and Treasurer. Mr. Fricker’s last day with the Company will be August 30, 2021.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1719406/000095014221002677/0000950142-21-002677-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.